SyncAblate gives the clinician live, directional guidance toward a respiratory-moving target — advance, hold, or adjust — and confirms the moment alignment is right before each move.
Liver & lung · biopsy and ablation · the clinician stays in control
In CT-guided liver and lung procedures, the clinician steers a needle toward a target that moves with every breath — judging direction and timing by eye and experience alone.
A liver or lung target can travel well over a centimetre with normal breathing — and substantially more under deeper breaths. A few millimetres is the difference between a clean sample and a missed one.
Respiratory belts and external markers measure chest-wall movement — a stand-in for the target, not the target itself. The relationship between the two is not fixed.
Whether the needle is on-line, and whether this is the moment to advance, are judged in real time by eye. The aligned window can last a fraction of a second.
SyncAblate adds one missing layer: clear, real-time guidance toward the target — advance, hold, or adjust — confirmed safe before each move. It does not replace the clinician, the CT, or the ultrasound, and it never moves the needle.
The system follows the target's motion in real time, rather than inferring it from the body surface.
It forecasts where the target will be roughly 200 milliseconds ahead, so guidance accounts for human reaction delay.
It turns that into a clear, real-time command — advance, hold, or adjust — and confirms alignment is safe before ever signalling advance. The guidance is the heart of it; the timing is what keeps it safe.
SyncAblate doesn't replace the clinician's hands — it guides them. Live, directional guidance to a moving target: advance, hold, adjust — confirmed at the moment alignment is right.
SyncAblate has been selected as a semi-finalist in the 2026 Australian Technologies Competition, in the MedTech & Pharma — Biotech, Device & Other category, from a field of more than 200 applications.
SyncAblate has been invited to present to the University of New South Wales IHealthE expert panel — bringing clinical, engineering, and regulatory perspectives together in one room.
Every figure below comes from computational simulation against published respiratory-motion data. The next step is a physical bench prototype.
Pre-prototype. Simulation-validated. No patient data. SyncAblate has not been built as a physical device and has not been used in any clinical procedure. All performance characteristics are derived from simulation and establish mathematical feasibility only — they are not clinical claims.
Clinical validation of the workflow and the value of real-time directional guidance at the point of commitment.
A guidance-and-safety layer designed to integrate with existing needle and ablation platforms.
Bench validation, motion-platform access, and the path from simulation to physical evidence.
An IP-protected concept at the pre-prototype stage with a defined route to first bench data.
Detailed materials are shared under a confidentiality agreement. If you're a clinician, manufacturer, research partner, or investor, get in touch to start the conversation.
Contact Frank Mirabito →